Health Canada drug identification number

DIN 01924559 — DEXEDRINE SPANSULE 10 MG

DEXEDRINE SPANSULE is a capsule (sustained-release) of Dextroamphetamine marketed by KNIGHT THERAPEUTICS INC.. The full Dextroamphetamine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
01924559
Brand name
DEXEDRINE SPANSULE
Active ingredient
Dextroamphetamine
Strength
10 MG
Dosage form
CAPSULE (SUSTAINED-RELEASE)
Route
ORAL
Manufacturer
KNIGHT THERAPEUTICS INC.
Health Canada status
MARKETED
Drug class
Central nervous system stimulant (amphetamine)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Dextroamphetamine products

DINBrandStrengthFormManufacturerStatus
01924516 DEXEDRINE 5 MG TABLET KNIGHT THERAPEUTICS INC. MARKETED
01924567 DEXEDRINE SPANSULE 15 MG CAPSULE (SUSTAINED-RELEASE) KNIGHT THERAPEUTICS INC. MARKETED
02443236 DEXTROAMPHETAMINE 5 MG TABLET AA PHARMA INC MARKETED
02448319 TEVA-DEXTROAMPHETAMINE SR 10 MG CAPSULE (SUSTAINED-RELEASE) TEVA CANADA LIMITED MARKETED
02448327 TEVA-DEXTROAMPHETAMINE SR 15 MG CAPSULE (SUSTAINED-RELEASE) TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.